Raleigh Capital Management Inc. trimmed its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 4.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,797 shares of the financial services provider’s stock after selling 408 shares during the period. Raleigh Capital Management Inc.’s holdings in MetLife were worth $802,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in MET. MeadowBrook Investment Advisors LLC boosted its stake in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 186 shares in the last quarter. Wolff Wiese Magana LLC increased its stake in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares during the period. Peterson Financial Group Inc. bought a new position in MetLife during the third quarter worth about $30,000. Finally, Retirement Wealth Solutions LLC acquired a new stake in MetLife during the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Trading Down 1.3 %
MET stock opened at $85.78 on Thursday. The business has a fifty day moving average of $83.68 and a 200-day moving average of $79.82. The company has a market cap of $59.39 billion, a P/E ratio of 17.29, a PEG ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
Analyst Upgrades and Downgrades
Several equities analysts recently commented on the company. BMO Capital Markets assumed coverage on MetLife in a research report on Thursday. They set a “market perform” rating and a $97.00 target price for the company. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. increased their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Piper Sandler upped their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Wells Fargo & Company cut their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $90.46.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Supercharge Your Portfolio With These 3 Key Stocks
- Investing in Travel Stocks Benefits
- Tide Shifts for 3M: How to Profit from the Rally
- Ride Out The Recession With These Dividend Kings
- Palantir Technologies: Another Stellar Year Ahead for the Stock?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.